S Hundt, U Haug, H Brenner - Ann Intern Med, 2009 - frost.propreventa.net Background: Different immunochemical fecal occult blood tests (FOBTs) have been
proposed for noninvasive colorectal cancer screening. Large-scale,
colonoscopy-based screening studies that allow evaluation of these tests ... Cited by 6 - Related articles - View as HTML - All 8 versions
DK Sohn, SY Jeong, HS Choi, S Lim, JM Huh, … - Cancer Research and Treatment, 2005 - pdf.medrang.co.kr Colorectal cancer is common in the Western world, and a significant cause of
death. In Eastern Europe, Japan and Korea, although the incidence of colorectal
cancer is lower than that in Western countries, a sharp increase in cases ... Cited by 5 - Related articles - View as HTML - All 5 versions
T Rubeca, S Rapi, M Confortini, M Brogioni, G … - The International journal of biological markers - ncbi.nlm.nih.gov We evaluated a new immunological fecal occult blood testing assay (FOB Gold,
Sentinel = SENT) compared to the assay currently employed in the Florence
screening program (OC-Hemodia, Eiken = OC). A total of 4,133 subjects were ... Cited by 6 - Related articles - BL Direct - All 5 versions
D Lieberman - Current Opinion in Gastroenterology, 2009 - journals.lww.com Introduction Colorectal cancer (CRC) remains the second leading cause of cancer
death in North America and the fourth most common cancer cause of death
globally. There is strong evidence that screening can reduce mortality and ... Related articles - All 8 versions
LGM van Rossum, AF van Rijn, RJF Laheij, … - British Journal of Cancer, 2009 - nature.com Dutch screening participants, 50–75 years of age, with average CRC risk and an
iFOBT value 50 ng ml -1 were offered colonoscopy. The detection rate was the
percentage of participants with CRC or advanced adenomas ( 10 mm, 20% ... Related articles - All 3 versions
M Li, W Chen, N Papadopoulos, SN Goodman, NC … - Nature Biotechnology, 2009 - indivumed.com Analysis of abnormally methylated genes is increasingly important in basic
research and in the development of cancer biomarkers1,2. We have developed
methyl-BEAMing technology to enable absolute quantification of the number ... Cited by 1 - Related articles - View as HTML - All 4 versions
LGM van Rossum, AF van Rijn, ALM Verbeek, … - Colorectal Cancer: To Screen or Not To Screen? That Is … - dare.ubn.kun.nl Chapter 2 ~ 52~ Random comparison of guaiac and immunochemical faecal occult
blood tests for colorectal cancer in a screening population. Leo GM van Rossum1,
Anne F van Rijn2, Robert JF Laheij1, Martijn GH van Oijen1, Paul Fockens2, ... Related articles - All 2 versions
TDNAB als Marker - rosenfluh.ch Gen wird fast ausschliesslich in Darmkrebs methyliert und kommt darum als
entspre- chender Biomarker infrage (mSEPT9-Test). «Solch ein Test zur
Darmkrebsvorsorge würde eine breitere Akzeptanz unter den Patienten und ... Related articles - View as HTML
- ►171.66.122.45 VJ Bailey, H Easwaran, Y Zhang, E Griffiths, … - Genome Research, 2009 - genome.cshlp.org DNA methylation contributes to carcinogenesis by silencing key tumor suppressor
genes. Here we report an ultrasensitive and reliable nanotechnology assay,
MS-qFRET, for detection and quantification of DNA methylation. Bisulfite- ... Cited by 1 - Related articles - All 9 versions
AF van Rijn, LGM van Rossum, M Deutekom, … - Journal of Medical Screening, 2008 - jms.rsmjournals.com Results The survey was completed by 9594 invitees (47%). Almost all responders
(99%) found the leaflet clear and readable. Almost all indicated that CRC can be
treated better if found early (99%). Only 20% of the responders answered ... Cited by 1 - Related articles - All 6 versions
